A detailed history of Birchview Capital, LP transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Birchview Capital, LP holds 7,365 shares of BHVN stock, worth $344,902. This represents 0.34% of its overall portfolio holdings.

Number of Shares
7,365
Previous 7,365 -0.0%
Holding current value
$344,902
Previous $255,000 44.31%
% of portfolio
0.34%
Previous 0.25%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$40.19 - $59.75 $295,999 - $440,058
7,365 New
7,365 $402,000
Q4 2022

Feb 03, 2023

SELL
$7.0 - $16.87 $51,555 - $124,247
-7,365 Reduced 50.0%
7,365 $102,000
Q3 2022

Nov 07, 2022

SELL
$144.95 - $152.29 $39,136 - $41,118
-270 Reduced 1.8%
14,730 $2.23 Million
Q2 2022

Aug 12, 2022

BUY
$83.14 - $145.99 $83,140 - $145,990
1,000 Added 7.14%
15,000 $2.19 Million
Q1 2022

May 13, 2022

BUY
$110.08 - $142.92 $220,160 - $285,840
2,000 Added 16.67%
14,000 $1.66 Million
Q4 2021

Feb 14, 2022

BUY
$99.73 - $148.48 $199,460 - $296,960
2,000 Added 20.0%
12,000 $1.65 Million
Q4 2019

Feb 12, 2020

BUY
$40.86 - $57.65 $408,600 - $576,500
10,000 New
10,000 $544,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.36B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.